Draft Document for Public Consultation: iCARDIO Alliance Global Implementation Guidelines on Ischemic Heart Disease Management 2026
Global Cardiology · 05.02.2026 · 4 (1)
DOI: 10.4081/cardio.2026.95 ↗Kurz gefasst
Leitlinie in der Zeitschrift Global Cardiology, online erschienen am 05.02.2026. Verfasst von Writing Task Force | iCARDIO-Alliance. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Ischemic heart disease (IHD) remains the leading cause of morbidity and mortality worldwide. Coronary artery disease (CAD) encompasses any pathological process capable of compromising myocardial perfusion and although numerous etiologies exist, including vasculitis, spontaneous coronary artery dissection, and coronary embolism, the majority of CAD is attributable to coronary atherosclerosis, which constitutes the focus of this document. For practical purposes, CAD is considered present when any degree of atherosclerotic involvement exceeds zero percent stenosis, recognizing that even minimal coronary atherosclerosis represents a systemic disease process with prognostic implications.
Zitieren
APA
iCARDIO-Alliance, W. T. F. (2026). Draft Document for Public Consultation: iCARDIO Alliance Global Implementation Guidelines on Ischemic Heart Disease Management 2026. Global Cardiology, 4(1). https://doi.org/10.4081/cardio.2026.95
Vancouver
iCARDIO-Alliance WTF. Draft Document for Public Consultation: iCARDIO Alliance Global Implementation Guidelines on Ischemic Heart Disease Management 2026. Global Cardiology. 2026;4(1). doi:10.4081/cardio.2026.95
BibTeX
@article{iCARDIOAlliance2026,
author = {iCARDIO-Alliance, Writing Task Force |},
title = {Draft Document for Public Consultation: iCARDIO Alliance Global Implementation Guidelines on Ischemic Heart Disease Management 2026},
journal = {Global Cardiology},
year = {2026},
volume = {4},
number = {1},
doi = {10.4081/cardio.2026.95}
}
EUVIMED